Junxun Ma
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 17
- Lung Cancer Research Studies 4
- Pancreatic and Hepatic Oncology Research 3
- Colorectal Cancer Treatments and Studies 3
-
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Yi Hu (26 shared papers)Haitao Tao (18 shared papers)Pengfei Cui (17 shared papers)Jinliang Wang (17 shared papers)Zhefeng Liu (8 shared papers)Shixue Chen (11 shared papers)Zhaozhen Wu (10 shared papers)Yuanyu Qian (7 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Therapeutic Advances in Medical Oncology (3 papers)Frontiers in Oncology (3 papers)Cancer Immunology Immunotherapy (3 papers)Translational Lung Cancer Research (3 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Junxun Ma
44 papers receiving 837 citations
Peers
Comparison fields: 5 of 64
- Oncology 493
- Pulmonary and Respiratory Medicine 239
- Immunology 106
- Cancer Research 60
- Gastroenterology 9
Countries citing papers authored by Junxun Ma
This map shows the geographic impact of Junxun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxun Ma more than expected).
Fields of papers citing papers by Junxun Ma
This network shows the impact of papers produced by Junxun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxun Ma. The network helps show where Junxun Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Junxun Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 92 | |
| 2 | 2021 | 91 | |
| 3 | 2013 | 75 | |
| 4 | 2021 | 49 | |
| 5 | 2019 | 39 | |
| 6 | 2021 | 36 | |
| 7 | 2015 | 35 | |
| 8 | 2020 | 33 | |
| 9 | 2020 | 29 | |
| 10 | 2020 | 27 | |
| 11 | 2020 | 27 | |
| 12 | 2020 | 25 | |
| 13 | 2020 | 25 | |
| 14 | 2020 | 23 | |
| 15 | 2015 | 21 | |
| 16 | 2021 | 21 | |
| 17 | 2018 | 20 | |
| 18 | 2014 | 18 | |
| 19 | 2019 | 18 | |
| 20 | 2019 | 15 |
About Junxun Ma
Junxun Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Surgery, having authored 45 papers that have together received 842 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), DNA Repair Mechanisms (2 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). The work is most often cited by research in Oncology (493 citations), Pulmonary and Respiratory Medicine (239 citations), Immunology (106 citations), Cancer Research (60 citations) and Gastroenterology (9 citations). Junxun Ma has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Yi Hu, Haitao Tao, Pengfei Cui, Jinliang Wang, Zhefeng Liu, Shixue Chen, Zhaozhen Wu, Yuanyu Qian, Di Huang and Ziwei Huang. Their work appears in journals such as Journal of Clinical Oncology, Therapeutic Advances in Medical Oncology, Frontiers in Oncology, Cancer Immunology Immunotherapy and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.